A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Abemaciclib
Related studies linked through entity extraction aliases.
Abemaciclib With or Without Atezolizumab for mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Abemaciclib in Indian Women With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
ABEMA Alone or in COMBO With MK-6482
- Status
- COMPLETED
- Phase
- PHASE1
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
- Status
- RECRUITING
- Phase
- PHASE2
ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1
PreOperative Endocrine Therapy for Individualised Care With Abemaciclib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
- Status
- TERMINATED
- Phase
- PHASE2
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE2